Although we did not find the modifying effect of SOD2 polymorphism on the risk for dyspnea development, the findings of the present study emphasize the potential incremental value of SOD2 genotyping to detect subclinical cardiac dysfunction in COVID-19 pateints. Here, SOD2 is linked to COVID-19.